Why Thermo Fisher Scientific Inc. (TMO) Stock Rose 8.7% on Jul 23, 2026
What happened
Thermo Fisher Scientific surged 9.32% after reporting Q2 2026 earnings that topped Wall Street expectations: adjusted EPS of $6.03 beat the $5.71 consensus, and revenue of $11.99 billion exceeded the $11.68–$11.72 billion forecast range, per Yahoo Finance and Zacks. Organic growth accelerated to 5% year-over-year, with adjusted operating margins expanding 90 basis points to 22.8%, signaling improving customer demand across all four operating segments. Volume reached 2.88 million shares—5.05x the expected level at this point in the session.
TMO expected to report Q2 2026 earnings July 23, 2026; watch for management guidance on academic/government demand recovery and Rapid DNA adoption rates.
Other developments that session
Thermo Fisher Scientific Inc. (TMO) filed a new 8-K on July 23, 2026. The audit did not disclose the specific contents of the filing.
Thermo Fisher Scientific Inc. (TMO) reported EPS of $6.03 vs. consensus estimate of $5.72 for Q2 FY2026, beating consensus by 5.4%.
Frequently asked questions
Why did Thermo Fisher Scientific Inc. (TMO) stock rise on Jul 23, 2026?
Thermo Fisher Scientific surged 9.32% after reporting Q2 2026 earnings that topped Wall Street expectations: adjusted EPS of $6.03 beat the $5.71 consensus, and revenue of $11.99 billion exceeded the $11.68–$11.72 billion forecast range, per Yahoo Finance and Zacks. Organic growth accelerated to 5% year-over-year, with adjusted operating margins expanding 90 basis points to 22.8%, signaling improving customer demand across all four operating segments. Volume reached 2.88 million shares—5.05x the expected level at this point in the session.
How much did TMO stock rise on Jul 23, 2026?
TMO rose 8.7% during the Jul 23, 2026 trading session.